Daiwa Securities Group Inc. Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Daiwa Securities Group Inc. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 79,858 shares of the medical equipment provider’s stock after selling 6,399 shares during the period. Daiwa Securities Group Inc.’s holdings in Intuitive Surgical were worth $41,683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in the business. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Down 3.8 %

NASDAQ ISRG opened at $518.26 on Monday. The business’s 50 day moving average is $571.36 and its two-hundred day moving average is $531.85. The stock has a market capitalization of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock valued at $7,756,844 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.